STOCK TITAN

Columbia Sptswr Financials

COLM
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Columbia Sptswr (COLM) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI COLM FY2025

Stable gross margins are being offset by rising operating overhead, leaving a still-cash-generative business with steadily thinner profits.

The sharp cash swing was mostly a working-capital story: inventory peaked at $1.03B in FY2022, and operating cash flow fell to -$25.2M even though the company remained profitable. As inventory normalized by FY2023, operating cash flow jumped to $636.3M while net income was only $251.4M, showing that cash generation was driven more by stock reduction than by stronger earnings.

Gross margin stayed around 50.5% in FY2025, yet operating margin fell to 6.1%; the merchandise economics look relatively intact, but overhead is claiming more of the value created. The key squeeze is below gross profit: SG&A has risen faster than sales for several years, so a mostly stable top line now supports much less operating income.

Liquidity remains a cushion rather than a constraint, with a current ratio of 2.6x and debt-to-equity at 0.7x in FY2025. That gives the company room to keep returning cash and absorbing seasonal swings, but it does not solve the core operating issue of weaker expense absorption.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 59 / 100
Financial Health Score 59/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Columbia Sptswr's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
63

Columbia Sptswr has an operating margin of 6.1%, meaning the company retains $6 of operating profit per $100 of revenue. This results in a moderate score of 63/100, indicating healthy but not exceptional operating efficiency. This is down from 8.0% the prior year.

Growth
28

Columbia Sptswr's revenue grew a modest 0.9% year-over-year to $3.4B. This slow but positive growth earns a score of 28/100.

Leverage
53

Columbia Sptswr has a moderate D/E ratio of 0.71. This balance of debt and equity financing earns a leverage score of 53/100.

Liquidity
70

With a current ratio of 2.59, Columbia Sptswr holds $2.59 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 70/100.

Cash Flow
68

Columbia Sptswr converts 6.4% of revenue into free cash flow ($216.7M). This strong cash generation earns a score of 68/100.

Returns
73

Columbia Sptswr earns a strong 10.4% return on equity (ROE), meaning it generates $10 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 73/100. This is down from 12.5% the prior year.

Altman Z-Score Safe
4.31

Columbia Sptswr scores 4.31, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
6/8

Columbia Sptswr passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
1.60x

For every $1 of reported earnings, Columbia Sptswr generates $1.60 in operating cash flow ($282.9M OCF vs $177.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$3.4B
YoY+0.9%
5Y CAGR+6.3%
10Y CAGR+3.9%

Columbia Sptswr generated $3.4B in revenue in fiscal year 2025. This represents an increase of 0.9% from the prior year.

EBITDA
$263.9M
YoY-19.2%
5Y CAGR+5.7%
10Y CAGR-1.5%

Columbia Sptswr's EBITDA was $263.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 19.2% from the prior year.

Net Income
$177.2M
YoY-20.6%
5Y CAGR+10.4%
10Y CAGR+0.2%

Columbia Sptswr reported $177.2M in net income in fiscal year 2025. This represents a decrease of 20.6% from the prior year.

EPS (Diluted)
$3.24
YoY-15.2%
5Y CAGR+14.9%
10Y CAGR+2.8%

Columbia Sptswr earned $3.24 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 15.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$216.7M
YoY-49.7%
5Y CAGR-2.6%
10Y CAGR+24.0%

Columbia Sptswr generated $216.7M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 49.7% from the prior year.

Cash & Debt
$442.0M
YoY-16.9%
5Y CAGR-11.0%
10Y CAGR+1.8%

Columbia Sptswr held $442.0M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
$1.20
YoY+0.0%
5Y CAGR+35.8%
10Y CAGR+6.8%

Columbia Sptswr paid $1.20 per share in dividends in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Shares Outstanding
52M
YoY-5.4%
5Y CAGR-4.6%
10Y CAGR-2.8%

Columbia Sptswr had 52M shares outstanding in fiscal year 2025. This represents a decrease of 5.4% from the prior year.

Margins & Returns

Gross Margin
50.5%
YoY+0.3pp
5Y CAGR+1.6pp
10Y CAGR+4.4pp

Columbia Sptswr's gross margin was 50.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.3 percentage points from the prior year.

Operating Margin
6.1%
YoY-1.9pp
5Y CAGR+0.6pp
10Y CAGR-4.6pp

Columbia Sptswr's operating margin was 6.1% in fiscal year 2025, reflecting core business profitability. This is down 1.9 percentage points from the prior year.

Net Margin
5.2%
YoY-1.4pp
5Y CAGR+0.9pp
10Y CAGR-2.3pp

Columbia Sptswr's net profit margin was 5.2% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.4 percentage points from the prior year.

Return on Equity
10.4%
YoY-2.2pp
5Y CAGR+4.5pp
10Y CAGR-2.1pp

Columbia Sptswr's ROE was 10.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 2.2 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
$201.1M
YoY-36.7%
5Y CAGR+8.6%
10Y CAGR+11.1%

Columbia Sptswr spent $201.1M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 36.7% from the prior year.

Capital Expenditures
$66.2M
YoY+10.6%
5Y CAGR+18.1%
10Y CAGR-0.5%

Columbia Sptswr invested $66.2M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 10.6% from the prior year.

COLM Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $779.0M-27.2% $1.1B+13.4% $943.4M+55.9% $605.2M-22.3% $778.5M-29.0% $1.1B+17.7% $931.8M+63.4% $570.2M
Cost of Revenue $384.1M-25.9% $518.5M+9.9% $471.6M+53.1% $308.1M-19.4% $382.4M-28.7% $536.0M+15.5% $464.2M+56.4% $296.8M
Gross Profit $395.0M-28.4% $551.7M+16.9% $471.8M+58.8% $297.1M-25.0% $396.1M-29.3% $560.5M+19.9% $467.6M+71.0% $273.4M
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $357.1M-19.1% $441.5M+15.9% $380.9M+17.0% $325.6M-8.1% $354.5M-17.7% $430.6M+19.2% $361.2M+19.3% $302.7M
Operating Income $42.0M-64.0% $116.7M+73.2% $67.4M+385.6% -$23.6M-150.7% $46.5M-66.1% $137.3M+22.0% $112.5M+572.8% -$23.8M
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax $13.0M-52.3% $27.2M+43.2% $19.0M+396.9% -$6.4M-150.6% $12.6M-66.1% $37.3M+28.4% $29.0M+995.7% -$3.2M
Net Income $34.3M-63.2% $93.1M+79.1% $52.0M+610.1% -$10.2M-124.1% $42.2M-58.8% $102.6M+13.8% $90.2M+867.9% -$11.7M
EPS (Diluted) $0.65 N/A $0.95+600.0% $-0.19-125.3% $0.75 N/A $1.56+880.0% $-0.20

COLM Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $2.6B-12.5% $2.9B+8.0% $2.7B-6.2% $2.9B+6.8% $2.7B-9.0% $3.0B+7.8% $2.8B0.0% $2.8B
Current Assets $1.6B-18.0% $2.0B+13.0% $1.7B-7.8% $1.9B+8.8% $1.7B-13.3% $2.0B+10.0% $1.8B-1.2% $1.8B
Cash & Equivalents $319.3M-27.8% $442.0M+93.2% $228.8M-46.5% $427.8M+32.3% $323.3M-39.2% $531.9M+73.4% $306.7M-10.3% $341.8M
Inventory $624.0M-9.5% $689.5M-13.9% $800.4M-13.7% $926.9M+48.6% $623.7M-9.7% $690.5M-13.5% $798.2M-3.1% $823.6M
Accounts Receivable $368.3M-8.6% $403.2M-34.0% $610.5M+110.1% $290.6M-25.1% $387.9M-7.1% $417.5M-28.2% $581.7M+161.3% $222.6M
Goodwill $5.7M0.0% $5.7M0.0% $5.7M-78.7% $26.7M0.0% $26.7M0.0% $26.7M0.0% $26.7M0.0% $26.7M
Total Liabilities $981.6M-19.4% $1.2B+15.3% $1.1B-14.5% $1.2B+23.9% $997.6M-16.5% $1.2B+22.8% $973.3M+3.9% $936.9M
Current Liabilities $527.1M-30.7% $760.8M+28.4% $592.7M-22.1% $761.3M+36.2% $558.8M-27.1% $766.5M+35.2% $566.9M+4.1% $544.4M
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity $1.6B-7.5% $1.7B+3.3% $1.7B+0.1% $1.7B-3.3% $1.7B-3.9% $1.8B-0.4% $1.8B-2.0% $1.8B
Retained Earnings $1.6B-7.3% $1.8B+3.1% $1.7B+0.1% $1.7B-2.9% $1.8B-3.9% $1.8B+0.3% $1.8B-2.2% $1.9B

COLM Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow -$77.5M-112.6% $616.3M+327.8% -$270.6M-777.1% -$30.8M+3.7% -$32.0M-105.6% $567.6M+406.0% -$185.5M-8850.0% $2.1M
Capital Expenditures $12.4M-36.2% $19.5M+17.5% $16.6M+14.8% $14.5M-7.0% $15.6M-13.9% $18.1M+29.5% $13.9M+7.4% $13.0M
Free Cash Flow -$90.0M-115.1% $596.8M+307.8% -$287.2M-533.7% -$45.3M+4.8% -$47.6M-108.7% $549.6M+375.5% -$199.4M-1734.4% -$10.9M
Investing Cash Flow $124.6M+134.6% -$359.8M-380.0% $128.5M-25.3% $172.0M+380.0% -$61.4M+73.7% -$233.8M-180.3% $291.2M+4168.1% -$7.2M
Financing Cash Flow -$169.6M-274.8% -$45.3M+20.0% -$56.6M-21.4% -$46.6M+60.7% -$118.6M-16.7% -$101.7M+30.2% -$145.6M-115.4% -$67.6M
Dividends Paid $15.6M-2.8% $16.1M-2.2% $16.4M0.0% $16.4M-1.0% $16.6M-1.6% $16.9M-2.1% $17.2M-2.6% $17.7M
Share Buybacks $150.0M+410.0% $29.4M-26.5% $40.0M+32.2% $30.3M-70.2% $101.4M+16.7% $86.9M-32.2% $128.2M+144.5% $52.5M

COLM Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin 50.7%-0.8pp 51.5%+1.5pp 50.0%+0.9pp 49.1%-1.8pp 50.9%-0.2pp 51.1%+0.9pp 50.2%+2.2pp 47.9%
Operating Margin 5.4%-5.5pp 10.9%+3.8pp 7.1%+11.0pp -3.9%-9.9pp 6.0%-6.6pp 12.5%+0.4pp 12.1%+16.3pp -4.2%
Net Margin 4.4%-4.3pp 8.7%+3.2pp 5.5%+7.2pp -1.7%-7.1pp 5.4%-3.9pp 9.3%-0.3pp 9.7%+11.7pp -2.1%
Return on Equity 2.2%-3.3pp 5.5%+2.3pp 3.1%+3.8pp -0.6%-3.1pp 2.5%-3.3pp 5.8%+0.7pp 5.0%+5.7pp -0.6%
Return on Assets 1.3%-1.8pp 3.2%+1.3pp 1.9%+2.3pp -0.4%-1.9pp 1.6%-1.9pp 3.5%+0.2pp 3.3%+3.7pp -0.4%
Current Ratio 3.07+0.5 2.59-0.4 2.95+0.5 2.49-0.6 3.12+0.5 2.62-0.6 3.22-0.2 3.39
Debt-to-Equity 0.62-0.1 0.71+0.1 0.64-0.1 0.75+0.2 0.58-0.1 0.67+0.1 0.54+0.0 0.51
FCF Margin -11.6%-67.3pp 55.8%+86.2pp -30.4%-22.9pp -7.5%-1.4pp -6.1%-56.2pp 50.1%+71.5pp -21.4%-19.5pp -1.9%

Similar Companies

Frequently Asked Questions

Columbia Sptswr (COLM) reported $3.4B in total revenue for fiscal year 2025. This represents a 0.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Columbia Sptswr (COLM) revenue grew by 0.9% year-over-year, from $3.4B to $3.4B in fiscal year 2025.

Yes, Columbia Sptswr (COLM) reported a net income of $177.2M in fiscal year 2025, with a net profit margin of 5.2%.

Columbia Sptswr (COLM) reported diluted earnings per share of $3.24 for fiscal year 2025. This represents a -15.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Columbia Sptswr (COLM) had EBITDA of $263.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Columbia Sptswr (COLM) had a gross margin of 50.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Columbia Sptswr (COLM) had an operating margin of 6.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Columbia Sptswr (COLM) had a net profit margin of 5.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Columbia Sptswr (COLM) paid $1.20 per share in dividends during fiscal year 2025.

Columbia Sptswr (COLM) has a return on equity of 10.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Columbia Sptswr (COLM) generated $216.7M in free cash flow during fiscal year 2025. This represents a -49.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Columbia Sptswr (COLM) generated $282.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Columbia Sptswr (COLM) had $2.9B in total assets as of fiscal year 2025, including both current and long-term assets.

Columbia Sptswr (COLM) invested $66.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Columbia Sptswr (COLM) spent $201.1M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Columbia Sptswr (COLM) had 52M shares outstanding as of fiscal year 2025.

Columbia Sptswr (COLM) had a current ratio of 2.59 as of fiscal year 2025, which is generally considered healthy.

Columbia Sptswr (COLM) had a debt-to-equity ratio of 0.71 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Columbia Sptswr (COLM) had a return on assets of 6.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Columbia Sptswr (COLM) has an Altman Z-Score of 4.31, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Columbia Sptswr (COLM) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Columbia Sptswr (COLM) has an earnings quality ratio of 1.60x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Columbia Sptswr (COLM) scores 59 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top